Background
In patients with pulmonary embolism (PE) and right ventricular dysfunction (RVD), in hospital mortality ranges from 5% to 17%, significantly higher than in patients without RVD. In randomized trials and clinical practice, systemic PE thrombolysis is associated with high bleeding risk. There is a need for effective treatment alternatives for acute PE that facilitate the reversal of RVD without causing an excess in systemic bleeding complications.
Materials-Methods
We performed a retrospective analysis of 10 intermediate risk PE patients (53±14 years) who were treated with Ultrasound-accelerated thrombolysis (USAT) using the EkoSonic® Endovascular System. They received contrast-enhanced chest computed tomography (CT) scans, transthoracic echocardiography (TTE) and pulmonary angiography at baseline, after USAT, and at 6 month follow-up.
Materials-Methods
We performed a retrospective analysis of 10 intermediate risk PE patients (53±14 years) who were treated with Ultrasound-accelerated thrombolysis (USAT) using the EkoSonic® Endovascular System. They received contrast-enhanced chest computed tomography (CT) scans, transthoracic echocardiography (TTE) and pulmonary angiography at baseline, after USAT, and at 6 month follow-up.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
